Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital
Objectives: Despite the scientific evidence of reducing cardiac events with HMG Co-A reductase inhibitors (statins) therapy in both primary and secondary preventions, these therapies continue to be underutilized in patients receiving convictional care. Simvastatin, a HMG Co-A inhibitor agent, is the...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oman Medical Specialty Board
2010-10-01
|
| Schriftenreihe: | Oman Medical Journal |
| Schlagworte: | |
| Online-Zugang: | http://www.omjournal.org/fultext_PDF.aspx?DetailsID=17&type=fultext |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|